| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 妇科类(元) | - | - | - | - | 42,250,562.64 |
| 糖尿病类(元) | - | 474,057,188.28 | 235,235,726.65 | 335,817,118.43 | 156,413,089.67 |
| 心血管类(元) | - | 84,210,323.29 | 69,554,279.27 | 189,688,496.53 | 138,353,767.14 |
| 药品推广服务(元) | -898,044.98 | - | - | - | - |
| 药品销售(元) | 310,538,359.81 | - | - | - | - |
| 其他(元) | 1,805,268.47 | 93,616,395.03 | 47,194,803.11 | 141,533,383.96 | 39,418,052.13 |
| 营业成本(元) | |||||
| 妇科类(元) | - | - | - | - | 28,775,488.74 |
| 糖尿病类(元) | - | 71,883,836.91 | 31,192,973.70 | 51,537,966.97 | 24,034,099.75 |
| 心血管类(元) | - | 76,508,989.59 | 59,402,840.72 | 172,156,444.17 | 126,108,395.28 |
| 药品推广服务(元) | - | - | - | - | - |
| 药品销售(元) | 58,965,343.53 | - | - | - | - |
| 其他(元) | - | 56,860,110.73 | 28,090,715.07 | 101,893,297.19 | 27,810,760.90 |
| 毛利(元) | |||||
| 妇科类(元) | - | - | - | - | 13,475,073.90 |
| 糖尿病类(元) | - | 402,173,351.37 | 204,042,752.95 | 284,279,151.46 | 132,378,989.92 |
| 心血管类(元) | - | 7,701,333.70 | 10,151,438.55 | 17,532,052.36 | 12,245,371.86 |
| 药品推广服务(元) | - | - | - | - | - |
| 药品销售(元) | 251,573,016.28 | - | - | - | - |
| 其他(元) | - | 36,756,284.30 | 19,104,088.04 | 39,640,086.77 | 11,607,291.23 |
| 毛利率(%) | |||||
| 妇科类(%) | - | - | - | - | 31.89 |
| 糖尿病类(%) | - | 84.84 | 86.74 | 84.65 | 84.63 |
| 心血管类(%) | - | 9.15 | 14.59 | 9.24 | 8.85 |
| 药品推广服务(%) | - | - | - | - | - |
| 药品销售(%) | 81.01 | - | - | - | - |
| 其他(%) | - | 39.26 | 40.48 | 28.01 | 29.45 |
| 收入构成(%) | |||||
| 妇科类(%) | - | - | - | - | 11.22 |
| 糖尿病类(%) | - | 72.72 | 66.83 | 50.34 | 41.55 |
| 心血管类(%) | - | 12.92 | 19.76 | 28.44 | 36.75 |
| 药品推广服务(%) | -0.29 | - | - | - | - |
| 药品销售(%) | 99.71 | - | - | - | - |
| 其他(%) | 0.58 | 14.36 | 13.41 | 21.22 | 10.47 |
| 毛利构成(%) | |||||
| 妇科类(%) | - | - | - | - | 7.94 |
| 糖尿病类(%) | - | 90.05 | 87.46 | 83.26 | 78.00 |
| 心血管类(%) | - | 1.72 | 4.35 | 5.13 | 7.22 |
| 药品推广服务(%) | 0.00 | - | - | - | - |
| 药品销售(%) | 100.00 | - | - | - | - |
| 其他(%) | 0.00 | 8.23 | 8.19 | 11.61 | 6.84 |